TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 91 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2017. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $0 | -100.0% | 19 | -97.3% | 0.00% | – |
| Q1 2019 | $1,000 | -50.0% | 700 | -50.9% | 0.00% | – |
| Q4 2018 | $2,000 | -75.0% | 1,426 | -50.9% | 0.00% | – |
| Q3 2018 | $8,000 | +60.0% | 2,902 | +94.0% | 0.00% | – |
| Q2 2018 | $5,000 | 0.0% | 1,496 | -7.5% | 0.00% | – |
| Q1 2018 | $5,000 | -28.6% | 1,618 | +36.3% | 0.00% | – |
| Q4 2017 | $7,000 | +40.0% | 1,187 | +65.3% | 0.00% | – |
| Q3 2017 | $5,000 | 0.0% | 718 | +2.6% | 0.00% | – |
| Q2 2017 | $5,000 | -16.7% | 700 | 0.0% | 0.00% | – |
| Q1 2017 | $6,000 | -94.2% | 700 | -97.2% | 0.00% | – |
| Q4 2016 | $103,000 | +1187.5% | 24,689 | +1024.3% | 0.00% | – |
| Q3 2016 | $8,000 | +166.7% | 2,196 | +211.9% | 0.00% | – |
| Q2 2016 | $3,000 | +50.0% | 704 | +87.7% | 0.00% | – |
| Q1 2016 | $2,000 | -97.6% | 375 | -95.5% | 0.00% | – |
| Q4 2015 | $84,000 | -95.2% | 8,362 | -96.5% | 0.00% | -100.0% |
| Q3 2015 | $1,764,000 | -78.9% | 236,378 | +33.8% | 0.00% | -80.0% |
| Q2 2015 | $8,378,000 | +29.0% | 176,607 | -0.4% | 0.01% | +25.0% |
| Q1 2015 | $6,495,000 | +129800.0% | 177,250 | +49136.1% | 0.01% | – |
| Q2 2014 | $5,000 | 0.0% | 360 | -44.6% | 0.00% | – |
| Q2 2013 | $5,000 | – | 650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 330,000 | $2,353,000 | 0.98% |
| EcoR1 Capital, LLC | 633,400 | $4,516,000 | 0.80% |
| DLD Asset Management, LP | 570,000 | $4,059,000 | 0.53% |
| Rhenman & Partners Asset Management AB | 300,000 | $2,139,000 | 0.31% |
| Eventide Asset Management | 600,000 | $4,278,000 | 0.27% |
| Tekla Capital Management LLC | 1,004,322 | $7,161,000 | 0.26% |
| Rock Springs Capital Management LP | 698,000 | $4,977,000 | 0.25% |
| DLD Asset Management, LP | 230,000 | $1,640,000 | 0.21% |
| Worth Venture Partners, LLC | 29,325 | $209,000 | 0.18% |
| Crestline Management, LP | 161,403 | $1,151,000 | 0.15% |